medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-4-28-35medsovet-73Research ArticleКАРДИОЛОГИЯCARDIOLOGYВлияние блокаторов рецепторов к ангиотензину II и антагонистов кальция на когнитивные функцииEffect of angiotensin II receptor blockers and calcium antagonists on cognitionОстроумоваО. Д.OstroumovaO. D.noemail@neicon.ruПервичкоЕ. И.PervichkoE. I.noemail@neicon.ruГалееваН. Ю.GaleevaN. Y.noemail@neicon.ruМосковский государственный медико-стоматологический университет им. А.И. Евдокимова; Первый Московский государственный медицинский университет им. И.М. СеченоваРоссияMoscow State University of Medicine and Dentistry named after A.I. Yevdokimov; First Moscow State Medical University named after I.M. SechenovRussian FederationМосковский государственный университет им. М.В. ЛомоносоваРоссияMoscow State University named after M.V. LomonosovRussian FederationГородская клиническая больница №70РоссияCity clinical hospital No.70Russian Federation201630122016042835Copyright © Остроумова О.Д., Первичко Е.И., Галеева Н.Ю., 20162016Остроумова О.Д., Первичко Е.И., Галеева Н.Ю.Ostroumova O.D., Pervichko E.I., Galeeva N.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/73

В статье приведены определение, классификация и патогенетические механизмы нарушения когнитивных функций при артериальной гипертонии. Обсуждаются возможности антигипертензивных препаратов разных классов в коррекции когнитивных нарушений и профилактике деменции. Рассмотрены потенциальные механизмы коррекции когнитивных функций на фоне лечения блока-торами рецепторов к ангиотензину II и антагонистами кальция.

The article offers a definition, classification and describes the pathogenetic mechanisms of cognitive impairment in patients with arterial hypertension. The potential of different classes of antihypertensive drugs in the management of cognitive impairment and dementia prevention is discussed. The possible mechanisms of the improvement of cognitive functions during treatment with angiotensin II receptor blockers and calcium antagonists are considered.

артериальная гипертониякогнитивные функциидеменцияантигипертензивная терапияантагонисты рецепторов к ангиотензину IIлозартанантагонисты кальцияамлодипинhypertensioncognitive functionsdementiaantihypertensive therapyangiotensin II receptor blockerslosartancalcium antagonistsamlodipineReferencesЗахаров В.В., Локшина А.Б. Когнитивные нарушения в общеклинической практике. М., 2009, 8 с.Захаров В.В., Локшина А.Б. Когнитивные нарушения в общеклинической практике. М., 2009, 8 с.Larrieu S, Letenneur L, Orgogozo JM. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 2002, 59: 1594-1599.Larrieu S, Letenneur L, Orgogozo JM. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 2002, 59: 1594-1599.Левин О.С. Диагностика и лечение деменции в клинической практике. М.: «МЕДпресс-информ», 248 с.Левин О.С. Диагностика и лечение деменции в клинической практике. М.: «МЕДпресс-информ», 248 с.Диагностика и лечение артериальной гипер-тензии. Журнал «Системные гипертензии», 2010, 3: 5-26.Диагностика и лечение артериальной гипер-тензии. Журнал «Системные гипертензии», 2010, 3: 5-26.Henderson AS. Dementia. World Health Organization, Geneva, 1994, 70 p.Henderson AS. Dementia. World Health Organization, Geneva, 1994, 70 p.Amaducci L, Andrea L. The epidemiology of the dementia in Europe. In: A Culebras, J Matias Cuiu, G Roman (eds): New concepts in vascular dementia. Barselona: Prous Science Publishers, 1993, pp 1927.Amaducci L, Andrea L. The epidemiology of the dementia in Europe. In: A Culebras, J Matias Cuiu, G Roman (eds): New concepts in vascular dementia. Barselona: Prous Science Publishers, 1993, pp 1927.Левин О.С., Дамулин И.В. Диффузные изменения белого вещества (лейкоареоз) и проблема сосудистойй деменции. В кн. под ред. Н.Н. Яхно, И.В. Дамулина: Достижения в нейроге-риатрии. 1995. Ч. 2. С. 189-231.Левин О.С., Дамулин И.В. Диффузные изменения белого вещества (лейкоареоз) и проблема сосудистойй деменции. В кн. под ред. Н.Н. Яхно, И.В. Дамулина: Достижения в нейроге-риатрии. 1995. Ч. 2. С. 189-231.Awad IA, Masaryk T, Magdinec M. Pathogenesis of subcortical hypertense lesions on MRI of the brain. Stroke, 1993, 24: 1339-1346.Awad IA, Masaryk T, Magdinec M. Pathogenesis of subcortical hypertense lesions on MRI of the brain. Stroke, 1993, 24: 1339-1346.Inzitari D, Marinoni M, Ginanneschi A. Patho-physiology of leucoaraiosis. In: New concepts in vascular dementia. A Culebras, J Matias Guiu, G Roman (eds). Barcelona: Prous Science Publishers. 1993: 103-113.Inzitari D, Marinoni M, Ginanneschi A. Patho-physiology of leucoaraiosis. In: New concepts in vascular dementia. A Culebras, J Matias Guiu, G Roman (eds). Barcelona: Prous Science Publishers. 1993: 103-113.Fisher CM. Lacunar strokes and infarcts. Neurology, 1982, 32: 871-876.Fisher CM. Lacunar strokes and infarcts. Neurology, 1982, 32: 871-876.Hachinski VC, Lassen NA, Marshall J. Multiinfarct dementia. A case of mental deterioration in the elderly. Lancet, 1974, 2: 207-210.Hachinski VC, Lassen NA, Marshall J. Multiinfarct dementia. A case of mental deterioration in the elderly. Lancet, 1974, 2: 207-210.Дамулин И.В. Сосудистая деменция. Неврологический Ж., 1999, 3(4): 411.Дамулин И.В. Сосудистая деменция. Неврологический Ж., 1999, 3(4): 411.Лурия А.Р Высшие корковые функции человека. Изд. 2. М.: издательство МГУ, 1969.Лурия А.Р Высшие корковые функции человека. Изд. 2. М.: издательство МГУ, 1969.Лурия А.Р. Основы нейропсихологии. М.: издательство МГУ, 1973.Лурия А.Р. Основы нейропсихологии. М.: издательство МГУ, 1973.Лурия.А.Р. Лобные доли и регуляция психических процессов. М.: изд-во Московского Университета, 1966.Лурия.А.Р. Лобные доли и регуляция психических процессов. М.: изд-во Московского Университета, 1966.Skoog I, Lernfelt B, Landahl S et al. 15-years longitudinal study of blood pressure and dementia. Lancet, 1996, 347: 1141-1145.Skoog I, Lernfelt B, Landahl S et al. 15-years longitudinal study of blood pressure and dementia. Lancet, 1996, 347: 1141-1145.Launer LI, Masaki K, Petrovitch H, Foley D, Havlik RJ. The assotiation between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA, 1995, 274: 1846-1851.Launer LI, Masaki K, Petrovitch H, Foley D, Havlik RJ. The assotiation between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA, 1995, 274: 1846-1851.Cacciatore F, Abete P, Ferrara N et al. The role of blood pressure in cognitive impairment in an elderly population. J. of Hypertension, 2002, 15: 0135-0142.Cacciatore F, Abete P, Ferrara N et al. The role of blood pressure in cognitive impairment in an elderly population. J. of Hypertension, 2002, 15: 0135-0142.Elias PK, D'Agostino RB, Elias MF, Wolf PA. Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp. Aging. Res., 1995, 21: 393-417.Elias PK, D'Agostino RB, Elias MF, Wolf PA. Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp. Aging. Res., 1995, 21: 393-417.Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J. Clin. Epidemiol., 2005, 58. 1308-1315.Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J. Clin. Epidemiol., 2005, 58. 1308-1315.Forette F, Seux M-L, Staessen JA et al. for the Syst-Eur Investigators. The Prevention of Dementia with Antihypertensive Treatment. New evidence from the Systolic Hypertension (Syst-Eur) Study. Arch Intern Med, 2002, 162(18): 2046-2052.Forette F, Seux M-L, Staessen JA et al. for the Syst-Eur Investigators. The Prevention of Dementia with Antihypertensive Treatment. New evidence from the Systolic Hypertension (Syst-Eur) Study. Arch Intern Med, 2002, 162(18): 2046-2052.Lithell H, Hansson L, Skoog I et al., SCOPE Study Group. The study on cognition and prognosis in the elderly (SCOPE). Principal results of a randomised double-blind intervention trial. J Hypertens, 2003, 21: 875-86.Lithell H, Hansson L, Skoog I et al., SCOPE Study Group. The study on cognition and prognosis in the elderly (SCOPE). Principal results of a randomised double-blind intervention trial. J Hypertens, 2003, 21: 875-86.PROGRESS collaborative study group. Randomised trial of perindopril based blood pressure-lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack. Lancet, 2001, 358: 1033-41.PROGRESS collaborative study group. Randomised trial of perindopril based blood pressure-lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack. Lancet, 2001, 358: 1033-41.Marpillat NL, Macquin-Mavier I, Tropeano A-I, Bachoud-Levi A-C, Maison P. Antihypertensive classes, cognitive decline andincidence of dementia: a networkmeta-analysis. Journal of Hypertension, 2013, 31(6): 1073-82.Marpillat NL, Macquin-Mavier I, Tropeano A-I, Bachoud-Levi A-C, Maison P. Antihypertensive classes, cognitive decline andincidence of dementia: a networkmeta-analysis. Journal of Hypertension, 2013, 31(6): 1073-82.Chiu W-C, Ho W-C, Lin M-H, Lee H-H, Yeh Y-Ch, Wang J-D, Chen P-Ch, Health Data Analysis in Taiwan (hDATa) Research Group. Angiotension receptor blockers reduce the risk of dementia. Journal of Hypertension, 2014, 32: 938-947.Chiu W-C, Ho W-C, Lin M-H, Lee H-H, Yeh Y-Ch, Wang J-D, Chen P-Ch, Health Data Analysis in Taiwan (hDATa) Research Group. Angiotension receptor blockers reduce the risk of dementia. Journal of Hypertension, 2014, 32: 938-947.Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ, 2010, 340: b5465.Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ, 2010, 340: b5465.Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of antihypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. J Alzheimers Dis, 2011, 26: 699-708.Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM. Associations of antihypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. J Alzheimers Dis, 2011, 26: 699-708.Hajjar I, Brown L, Mack WJ, Chui H. Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series. Arch. Neurol., 2012, 69(12): 1632-1638.Hajjar I, Brown L, Mack WJ, Chui H. Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series. Arch. Neurol., 2012, 69(12): 1632-1638.Hanon O, Pequignot R. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens., 2006, 24(10): 2101-7.Hanon O, Pequignot R. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens., 2006, 24(10): 2101-7.Paran E, Anson O, Lowenthal DT. Cognitive Function and Antihypertensive Treatment in the Elderly: A 6-Year Follow-up Study. American Journal of Therapeutics, 2010, 17: 358-364.Paran E, Anson O, Lowenthal DT. Cognitive Function and Antihypertensive Treatment in the Elderly: A 6-Year Follow-up Study. American Journal of Therapeutics, 2010, 17: 358-364.Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone A, Carmela Iarussi D, Iacono A. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am. J. Hypertens. 1999, 12: 1130-4.Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone A, Carmela Iarussi D, Iacono A. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am. J. Hypertens. 1999, 12: 1130-4.Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E, Preti P. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens, 2003, 17: 781-785.Fogari R, Mugellini A, Zoppi A, Derosa G, Pasotti C, Fogari E, Preti P. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens, 2003, 17: 781-785.Schrader J, Luders S, Diener HC et al. Effects of long-term antihypertensive therapy with losar-tan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study. Med. Klin. (Munich), 2008, 103 (7): 491-499.Schrader J, Luders S, Diener HC et al. Effects of long-term antihypertensive therapy with losar-tan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study. Med. Klin. (Munich), 2008, 103 (7): 491-499.Boutitie F., Oprisiu R., Achard J.M. et al. Does the change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II. J. Hypertension, 2007, 25: 1543-1553.Boutitie F., Oprisiu R., Achard J.M. et al. Does the change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II. J. Hypertension, 2007, 25: 1543-1553.Fournier A, Messerli FH, Achard JM and Fernandez L. Cerebroprotection mediated by angiotensin II A hypothesis supported by recent randomized clinical trials. J. Am. Coll. Cardiol., 2004, 43: 1343-1347.Fournier A, Messerli FH, Achard JM and Fernandez L. Cerebroprotection mediated by angiotensin II A hypothesis supported by recent randomized clinical trials. J. Am. Coll. Cardiol., 2004, 43: 1343-1347.Boutitie F, Oprisiu R, Achard JM et al. Does the change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II. J. Hypertension, 2007, 25: 1543-1553.Boutitie F, Oprisiu R, Achard JM et al. Does the change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II. J. Hypertension, 2007, 25: 1543-1553.Blume A, Funk A, Gohlke P, Unger T, Culman J. AT2 receptor inhibition in the rat brain reverses the beneficial of AT1 receptor blockade on neurological outcome after focal brain ischemia. Hypertension, 2000, 36: 256.Blume A, Funk A, Gohlke P, Unger T, Culman J. AT2 receptor inhibition in the rat brain reverses the beneficial of AT1 receptor blockade on neurological outcome after focal brain ischemia. Hypertension, 2000, 36: 256.Schrader J, Luders S, Kulschewski A et al. Morbidity and Mortality After Stroke. Eprosartan Compared with Nitrendipine for Secondery Prevention: principal results of a prospective randomized controlled study (MOSES). Stroke, 2005, 36: 1218-1226.Schrader J, Luders S, Kulschewski A et al. Morbidity and Mortality After Stroke. Eprosartan Compared with Nitrendipine for Secondery Prevention: principal results of a prospective randomized controlled study (MOSES). Stroke, 2005, 36: 1218-1226.Wang J, Ho L, Chen L, Zhao Z, Zhao W, Oian X, et al. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest, 2007, 117: 3393-3402.Wang J, Ho L, Chen L, Zhao Z, Zhao W, Oian X, et al. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest, 2007, 117: 3393-3402.Mogi M, Li JM, Tsukuda K, Iwanami J, Min LJ, Sakata A et al. Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. Biochem Biophys Res Commun, 2008, 375: 446-449.Mogi M, Li JM, Tsukuda K, Iwanami J, Min LJ, Sakata A et al. Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. Biochem Biophys Res Commun, 2008, 375: 446-449.Остроумова О.Д., Первичко Е.И. Влияние амлодипина на когнитивные функции у пожилых больных артериальной гипертонией. Фарматека, 2013, 13: 68-74.Остроумова О.Д., Первичко Е.И. Влияние амлодипина на когнитивные функции у пожилых больных артериальной гипертонией. Фарматека, 2013, 13: 68-74.Parneti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer's disease: the way forward. Drugs, 1997, 53: 752-768.Parneti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer's disease: the way forward. Drugs, 1997, 53: 752-768.Mason RP, Leeds PR, Jacob PF et al. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J. Neurochem., 1999, 72: 1448-56.Mason RP, Leeds PR, Jacob PF et al. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J. Neurochem., 1999, 72: 1448-56.Zipfel GJ, Lee JM, Choi DW/ Reducing calcium overload in the ischemic brain. N. Engl. J. Med., 1999, 341: 1543-4.Zipfel GJ, Lee JM, Choi DW/ Reducing calcium overload in the ischemic brain. N. Engl. J. Med., 1999, 341: 1543-4.Thibault O, Porter NM, Chen KC. Calcium Dysregulation in neuronal aging and Alzheimer's disease: hystory and new directions. Cell. Calcium, 1998, 25: 417-33.Thibault O, Porter NM, Chen KC. Calcium Dysregulation in neuronal aging and Alzheimer's disease: hystory and new directions. Cell. Calcium, 1998, 25: 417-33.Poscale A, Etchoberrigaray R. Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities. Pharmacol Res, 1999, 39: 81-88.Poscale A, Etchoberrigaray R. Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities. Pharmacol Res, 1999, 39: 81-88.Hong YL. The relationship between calcium antagonist-induced hypotension and central monoaminergic system in spontaneously hypertensive rats. Int J Clin Pharmacol Ther Toxicol, 1987, 11: 589-97.Hong YL. The relationship between calcium antagonist-induced hypotension and central monoaminergic system in spontaneously hypertensive rats. Int J Clin Pharmacol Ther Toxicol, 1987, 11: 589-97.Murzenok PP, Huang BS, Leenen FHH. Sympathoinhibition by central and periferal infusion of nifedipine in spontaneously hypertensive rats. Hypertension, 2000, 35: 631-6.Murzenok PP, Huang BS, Leenen FHH. Sympathoinhibition by central and periferal infusion of nifedipine in spontaneously hypertensive rats. Hypertension, 2000, 35: 631-6.Gould RJ, Murphy KMM, Snyder SH. Autoradiographic localization of calcium channel antagonist receptors in rats brain with [3H] nitrendipine. Brain Res, 1985, 330: 217-233.Gould RJ, Murphy KMM, Snyder SH. Autoradiographic localization of calcium channel antagonist receptors in rats brain with [3H] nitrendipine. Brain Res, 1985, 330: 217-233.Zakharov V.V., Lokshina A.B. Cognitive impairment in general clinical practice. М., 2009, 8 p.Zakharov V.V., Lokshina A.B. Cognitive impairment in general clinical practice. М., 2009, 8 p.Levin O.S. Diagnosis and treatment of dementia in outpatient practice. М.: MEDpressInform, 248 p.Levin O.S. Diagnosis and treatment of dementia in outpatient practice. М.: MEDpressInform, 248 p.Diagnosis and treatment of hypertension. Sistemnye Gipertenzii, 2010, 3: 5-26.Diagnosis and treatment of hypertension. Sistemnye Gipertenzii, 2010, 3: 5-26.Levin O.S., Damulin I.V. Diffuse white matter changes (leukoaraiosis) and the problem of vascular dementia. Book ed. by N.N. Yakhno, I.V. Damulin: Advances in neurogeriatrics. 1995. P. 2. P. 189-231.Levin O.S., Damulin I.V. Diffuse white matter changes (leukoaraiosis) and the problem of vascular dementia. Book ed. by N.N. Yakhno, I.V. Damulin: Advances in neurogeriatrics. 1995. P. 2. P. 189-231.Damulin I.V. Vascular dementia. Nevrologicheskiy Zh., 1999, 3(4): 411.Damulin I.V. Vascular dementia. Nevrologicheskiy Zh., 1999, 3(4): 411.Luria A.R. Human higher cortical functions. Ed. 2. М.: MSU, 1969.Luria A.R. Human higher cortical functions. Ed. 2. М.: MSU, 1969.Luria A.R. Basics of neuropsychology. М.: MSU, 1973.Luria A.R. Basics of neuropsychology. М.: MSU, 1973.Luriya .R. The frontal lobes and regulation of mental process. М.: MSU, 1966.Luriya .R. The frontal lobes and regulation of mental process. М.: MSU, 1966.Ostroumova O.D., Pervichko E.I. Effect of amlodipine on cognitive function in elderly hypertensive patients. Pharmateka, 2013, 13: 68-74.Ostroumova O.D., Pervichko E.I. Effect of amlodipine on cognitive function in elderly hypertensive patients. Pharmateka, 2013, 13: 68-74.

The authors declare that there are no conflicts of interest present.